NCT05179512View on ClinicalTrials.gov

Replication of the INSPIRE Trial in Healthcare Claims Data

CompletedOBSERVATIONAL
Enrollment

98,278

Participants

Timeline

Start Date

September 22, 2020

Primary Completion Date

August 30, 2021

Study Completion Date

August 30, 2021

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Tiotropium

Tiotropium dispensing claim is used as the reference group.

DRUG

salmeterol-fluticasone

Salmeterol/Fluticasone dispensing claim is used as the exposure group.

Trial Locations (1)

02120

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT05179512 - Replication of the INSPIRE Trial in Healthcare Claims Data | Biotech Hunter | Biotech Hunter